Close
  Indian J Med Microbiol
 

Figure 6: Antiviral activity of soyasapogenols; SSA (25 µg/ml), SSB (25 µg/ml), SSD (25 µg/ml), SSF (12.5 µg/ml) and total soyasaponin extract (TSSE) (100 µg/ml) against three viruses: Rift Valley fever virus (RVFV), vesicular stomatitis virus (VSV) and hepatitis A virus (HAV). Recombinant human interferon α2a (rh-IFN α2a, 10 IU/0.1 ml) was used as a positive control. Values are mean±SD of three separate experiments, each in triplicate.

Figure 6: Antiviral activity of soyasapogenols; SSA (25 µg/ml), SSB (25 µg/ml), SSD (25 µg/ml), SSF (12.5 µg/ml) and total soyasaponin extract (TSSE) (100 µg/ml) against three viruses: Rift Valley fever virus (RVFV), vesicular stomatitis virus (VSV) and hepatitis A virus (HAV). Recombinant human interferon α2a (rh-IFN α2a, 10 IU/0.1 ml) was used as a positive control. Values are mean±SD of three separate experiments, each in triplicate.